Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic pays $8 million for Cardima's patents:

This article was originally published in Clinica

Executive Summary

Medtronic is to pay $8 million for part of Cardima's patent portfolio and related intellectual property relating to intravascular sensing and signal detection and some guiding catheters. Fremont, California-based Cardima has a co-exclusive, perpetual, fully-paid licence to use the patents for mapping and ablation, its core business. "This transaction enables us to get full value for an area of business we were not previously focused on, to gain non-dilutive funds and to stay focused on completing our atrial fibrillation phase III clinical trial," said Gabriel Vegh, Cardima's president and CEO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel